Invention Grant
- Patent Title: Urea-substituted indanes as P38 map kinase inhibitors
-
Application No.: US15505902Application Date: 2015-08-27
-
Publication No.: US09963463B2Publication Date: 2018-05-08
- Inventor: Milind Rode , Sanjay Srivastava , Davindar Tuli , Deepak Rai , Prashant Gj , Shailesh Deshpande , Rameshchandra Gupta , Vijay Chauthaiwale , Chaitanya Dutt
- Applicant: TORRENT PHARMACEUTICALS LIMITED
- Applicant Address: IN Ahmedabad, Gujarat
- Assignee: Torrent Pharmaceuticals Limited
- Current Assignee: Torrent Pharmaceuticals Limited
- Current Assignee Address: IN Ahmedabad, Gujarat
- Agent Melissa M. Hayworth; Daniel R. Evans; E. Joseph Gess
- Priority: IN2772/MUM/2014 20140829
- International Application: PCT/IB2015/056505 WO 20150827
- International Announcement: WO2016/030852 WO 20160303
- Main IPC: A61K31/17
- IPC: A61K31/17 ; C07C275/28 ; C07D495/04 ; C07D487/04 ; C07D241/08
Abstract:
The present invention relates to novel indanyl urea derivatives of formula (I): their pharmaceutically acceptable salts, and their isomers, steroisomers, atropisomers, conformers, tautomers, polymorphs, hydrates and solvates. The present invention also encompasses process for preparing novel compounds and pharmaceutical composition of said compounds. The invention further relates to the use of the compounds for the preparation of medicament for use as pharmaceuticals.
Public/Granted literature
- US20170247390A1 P38 MAP KINASE INHIBITING INDANYL UREA COMPOUNDS Public/Granted day:2017-08-31
Information query
